Cancer News and Research

Latest Cancer News and Research

Renin test can predict appropriate drugs for BP patients: Study

Commonly prescribed drugs used to lower blood pressure can actually have the opposite effect-raising blood pressure in a statistically significant percentage of patients. A new study by researchers at Albert Einstein College of Medicine of Yeshiva University suggests that doctors could avoid this problem-and select drugs most suitable for their patients-by measuring blood levels of the enzyme renin through a blood test that is becoming more widely available. The study appears in the online edition of the American Journal of Hypertension.

20 Aug 2010

Muscle mass plays key role in cancer survival: Research

In the vast majority of patients with advanced cancer, their muscles will gradually waste away for reasons that have never been well understood. Now, researchers reporting in the August 20 issue of Cell, a Cell Press Publication, have found some new clues and a way to reverse that process in mice. What's more, animals with cancer that received the experimental treatment lived significantly longer, even as their tumors continued to grow.

20 Aug 2010

MUH performs first intracranial radiosurgery with Leksell Gamma Knife Perfexion system

Macquarie University Hospital (MUH) performed Australia's first Gamma Knife surgery with its new Leksell Gamma Knife Perfexion system, making it the country's first and only center capable of providing dedicated intracranial radiosurgery.

20 Aug 2010

Research marks new direction to treat Pneumocystis, inflammatory diseases

A drug to treat inflammation plays a surprising role reducing the level of infection caused by an opportunistic bug that is deadly for AIDS and cancer patients and others with weakened immune systems.

20 Aug 2010

Study on multisensory processing in autistic children

A new study by researchers at Albert Einstein College of Medicine of Yeshiva University has provided concrete evidence that children with autism spectrum disorders (ASD) process sensory information such as sound, touch and vision differently than typically developing children.

20 Aug 2010

Intake of green leafy vegetables reduces risk of developing type 2 diabetes

Eating more green leafy vegetables can significantly reduce the risk of developing type 2 diabetes, finds research published today on bmj.com.

20 Aug 2010

Muscular Dystrophy Association awards $14.1M in new grants

The Muscular Dystrophy Association, which has invested almost $39 million in 2010 in worldwide research seeking treatments and cures for muscle diseases, today announced that it has awarded $14.1 million in new grants.

20 Aug 2010

Schwarzenegger announces Calif. health IT network plan

Los Angeles Times: California Governor Arnold Schwarzenegger unveiled a high-tech vision for his state Tuesday, including an unprecedentedly broad computer network. "Schwarzenegger joined U.S. Chief Technology Officer Aneesh Chopra at the UC Davis Cancer Center on Tuesday to announce the launch of the country's largest 'telehealth' system, which organizers say will one day connect patients to hundreds of hospitals and clinics statewide using broadband technology." The broadband network will be devoted entirely to the health care sector (Hennessy-Fiske, 8/18).

20 Aug 2010

Bioniche provides update on Urocidin clinical development program for non-muscle-invasive bladder cancer

Bioniche Life Sciences Inc., a research-based, technology driven Canadian biopharmaceutical company, today provided an update on the clinical development program for its proprietary product for non-muscle-invasive bladder cancer - Urocidin.

20 Aug 2010

Study reports uneven decline of colorectal cancer mortality rate

Black patients die from colorectal cancer at much higher rates than whites do and new research points to unequal health care as the cause. While deaths from colorectal cancer have declined over the past 40 years, the declines have been uneven, said lead author Samir Soneji, Ph.D., of the Robert Wood Johnson Health and Society Scholars Program at the University of Pennsylvania.

20 Aug 2010

FDA grants Acceleron's ACE-031 orphan designation for treatment of DMD

Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced the United States Food and Drug Administration (FDA) granted orphan designation for ACE-031 for the treatment of Duchenne Muscular Dystrophy (DMD), a fatal neuromuscular disease in which patients experience a progressive loss of muscle mass and strength. ACE-031 is an investigational protein therapeutic being developed to increase muscle mass and strength.

20 Aug 2010

Today's Opinions: Vouchers and Medicare; The shortage of doctors; Eliminating health system's disparities; Protecting cancer patients

With the ambition of reducing the federal debt, Congressman Paul Ryan has offered a proposal to convert Medicare to a voucher-based program. … Though rarely described this way, the private Medicare Advantage plans are a (voluntary) voucher system (Austin Frakt, 8/19).

20 Aug 2010

First Edition: August 19, 2010

In the news today, modest premium increases are ahead for Medicare drug plans while a survey finds that big employers expect health cost hikes in 2011.

20 Aug 2010

New avenues for stem cell research

According to researchers at the University of NSW a new way has been found to generate stem cells from human skin - known as induced pluripotent stem (iPS) cells. A paper outlining the breakthrough was published this week in the US-based international online journal PLoS One.

19 Aug 2010

Stars line-up for Stand Up To Cancer's translational research initiative

An extraordinary line-up of actors, musicians, athletes and journalists have banded together for Stand Up To Cancer (SU2C), the groundbreaking initiative aimed at raising funds to accelerate innovative cancer research bringing new therapies to patients quickly that will saves lives now.

19 Aug 2010

Advaxis completes low dose group patient dosing in phase II cervical dysplasia clinical trial study

Advaxis, Inc.,the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, has completed the nine (9) doses to be administered to the three (3) vanguard patients in the low dose group of its phase II cervical dysplasia clinical trial study.

19 Aug 2010

Protection from unrealistic claims of Direct to consumer genetic tests needed

Direct to consumer (DTC) genetic tests are increasingly being marketed to the public via television, print ads, and the Internet. These home genetic tests provide access to a person's genomic information without necessarily involving a doctor or insurance company in the process.

19 Aug 2010

Us TOO International Prostate Cancer Education & Support Network recognized for 20 years of service

The prostate cancer community joins together in congratulating Us TOO International Prostate Cancer Education & Support Network in their 20th anniversary of continued prostate cancer support, education and advocacy.

19 Aug 2010

Celera Corporation releases review article on KIF6 gene variant for CHD

Celera Corporation today announced the publication of a review article on the KIF6 gene variant as a predictor of risk of coronary heart disease (CHD) and reduction of CHD events from statin therapy.

19 Aug 2010

Montana State University offers new biomedical technologies for prevention, treatment of viral infections

Researchers at Montana State University have developed six new biomedical technologies that could have applications for treating antibiotic resistant infections, fungal infections and viral infections; boosting humans' innate immunity and improving scientists' ability to study such compounds. The technologies are available for licensing to interested companies and entrepreneurs.

19 Aug 2010

Cancer News and Research

Latest Cancer News and Research

Renin test can predict appropriate drugs for BP patients: Study

Muscle mass plays key role in cancer survival: Research

MUH performs first intracranial radiosurgery with Leksell Gamma Knife Perfexion system

Research marks new direction to treat Pneumocystis, inflammatory diseases

Study on multisensory processing in autistic children

Intake of green leafy vegetables reduces risk of developing type 2 diabetes

Muscular Dystrophy Association awards $14.1M in new grants

Schwarzenegger announces Calif. health IT network plan

Bioniche provides update on Urocidin clinical development program for non-muscle-invasive bladder cancer

Study reports uneven decline of colorectal cancer mortality rate

FDA grants Acceleron's ACE-031 orphan designation for treatment of DMD

Today's Opinions: Vouchers and Medicare; The shortage of doctors; Eliminating health system's disparities; Protecting cancer patients

First Edition: August 19, 2010

New avenues for stem cell research

Stars line-up for Stand Up To Cancer's translational research initiative

Advaxis completes low dose group patient dosing in phase II cervical dysplasia clinical trial study

Protection from unrealistic claims of Direct to consumer genetic tests needed

Us TOO International Prostate Cancer Education & Support Network recognized for 20 years of service

Celera Corporation releases review article on KIF6 gene variant for CHD

Montana State University offers new biomedical technologies for prevention, treatment of viral infections

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in